SCHEMBL2593722

SCHEMBL2593722

CCOC(=O)Cc1cccc(-c2ccccc2)c1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
CYP4F2 P78329 2/20 0.44
CYP4A11 Q02928 2/20 0.44
NR1H4 Q96RI1 1/20 0.44
LMNA P02545 2/20 0.44
PKM P14618 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
TRPM8 Q7Z2W7 1/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
PDCD1 Q15116 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
MAPT P10636 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PTPN1 P18031 1/20 0.42
HSD17B10 Q99714 2/20 0.41
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3410569 0.90 FOLH1 (0.43) PPARGCYP4F2CYP4A11LMNAPKM
SCHEMBL25911838 0.89 SMN1; SMN2 (0.45) PPARGSMN1; SMN2CYP4F2CYP4A11LMNA
SCHEMBL2390130 0.85 CYP4F2 (0.51) PPARGSMN1; SMN2CYP4F2CYP4A11LMNA
SCHEMBL11291420 0.84 NR1H4 (0.55) NR1H4KDM4EALDH1A1HPGDPDCD1
SCHEMBL23425638 0.83 TRPM8 (0.48) SMN1; SMN2CYP4F2CYP4A11LMNAPKM
SCHEMBL21438076 0.81 NLRP3 (0.47) SMN1; SMN2CYP4F2CYP4A11LMNAPKM
SCHEMBL6366424 0.80 LMNA (0.54) SMN1; SMN2LMNAPKML3MBTL1KDM4E
SCHEMBL31075841 0.78 NLRP3 (0.47) SMN1; SMN2CYP4F2CYP4A11LMNAPKM
SCHEMBL31063021 0.78 NLRP3 (0.47) SMN1; SMN2CYP4F2CYP4A11LMNAPKM
SCHEMBL26474562 0.77 LMNA (0.46) SMN1; SMN2LMNAPKML3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2566580-A1 PROCESS FOR THE PREPARATION OF BIMOSIAMOSE Revotar Biopharmaceuticals AG (DE) 2013-03-13 EP disclosed
WO-2011138365-A1 PROCESS FOR THE PREPARATION OF BIMOSIAMOSE REVOTAR BIOPHARMACEUTICALS AG (DE) 2011-11-10 WO disclosed